<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Care</journal-id><journal-id journal-id-type="hwp">diacare</journal-id><journal-id journal-id-type="pmc">dcare</journal-id><journal-id journal-id-type="publisher-id">Diabetes Care</journal-id><journal-title-group><journal-title>Diabetes Care</journal-title></journal-title-group><issn pub-type="ppub">0149-5992</issn><issn pub-type="epub">1935-5548</issn><publisher><publisher-name>American Diabetes Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25715416</article-id><article-id pub-id-type="pmc">5321253</article-id><article-id pub-id-type="publisher-id">er03</article-id><article-id pub-id-type="doi">10.2337/dc15-er03</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:<related-article id="d35e32" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.2337/dc13-2761" vol="37" page="2149">2149&#x02013;2158</related-article></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nauck</surname><given-names>Michael</given-names></name></contrib><contrib contrib-type="author"><name><surname>Weinstock</surname><given-names>Ruth S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Umpierrez</surname><given-names>Guillermo E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Guerci</surname><given-names>Bruno</given-names></name></contrib><contrib contrib-type="author"><name><surname>Skrivanek</surname><given-names>Zachary</given-names></name></contrib><contrib contrib-type="author"><name><surname>Milicevic</surname><given-names>Zvonko</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>3</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>12</day><month>2</month><year>2015</year></pub-date><volume>38</volume><issue>3</issue><fpage>538</fpage><lpage>538</lpage><permissions><copyright-statement>&#x000a9; 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</copyright-statement><copyright-year>2015</copyright-year></permissions><self-uri xlink:title="pdf" xlink:href="dc15er03.pdf"/><counts><page-count count="1"/></counts></article-meta></front><body><p>In the print version of the article listed above, there is an error in four references cited in the <sc>conclusions</sc> section. On page 2156, references 3 and 4 should be listed as 5 and 6 in the sentences &#x0201c;Greater improvements in glycemic control with dulaglutide were also evident in the significantly higher percentage of patients who achieved HbA<sub>1c</sub> targets of &#x0003c;7.0% (53 mmol/mol) and &#x02264;6.5% (48 mmol/mol) than with sitagliptin. In addition, the results of this trial showed that the difference in glucose-lowering effects between dulaglutide and sitagliptin was sustained over a longer period of time (i.e., 52 weeks) compared with previously published trials that compared sitagliptin to a GLP-1 receptor agonist for up to 26 weeks (3,4).&#x0201d; On page 2156, references 5 and 6 should be listed as reference 7 in the sentence &#x0201c;Dulaglutide-treated patients achieved an early improvement (after 2 weeks) in fasting glucose consistent with the reported pharmacokinetic characteristics of the drug (5,6).&#x0201d;</p><p>The online version reflects these changes.</p></body></article>